MedPath

Evaluation of Efficacy and Safety of VX-548 for Painful Lumbosacral Radiculopathy (PLSR)

Phase 2
Completed
Conditions
Painful Lumbosacral Radiculopathy
Interventions
Drug: Placebo
Registration Number
NCT06176196
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Brief Summary

The purpose of the study is to evaluate the efficacy and safety of VX-548 in treating participants with PLSR.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
218
Inclusion Criteria
  • Body weight greater than or equal to (>=)45 kilogram (kg)
  • Body mass index (BMI) less than or equal to (<=) 40 kg/ meter square (m^2)
  • Diagnosis of PLSR for greater than (>)3 months as per criteria pre-specified in the protocol
  • Weekly average of daily NPRS score >=4 and <10 with limited variation in the 7-day Run-in Period

Key

Exclusion Criteria
  • More than 3 missing daily NPRS scores during the 7-day Run-in Period
  • Moderate or severe painful neuropathy other than PLSR as pre-specified in the protocol
  • History of prior lumbar spine surgery (e.g., discectomies, laminectomies, foraminotomies, or fusion)

Other protocol defined Inclusion/Exclusion criteria may apply.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
VX-548VX-548Participants will receive VX-548 up to 12 weeks.
PlaceboPlaceboParticipants will receive placebo matched to VX-548 up to 12 weeks.
Primary Outcome Measures
NameTimeMethod
Change From Baseline in the Weekly Average of Daily leg Pain Intensity on a Numeric Pain Rating Scale (NPRS)Baseline, Week 12
Secondary Outcome Measures
NameTimeMethod
Change From Baseline in the Weekly Average of the Daily Sleep Interference Scale (DSIS)Baseline, Week 12
Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs) and Serious Adverse Events (SAEs)From Day 1 up to Week 14

Trial Locations

Locations (54)

ARSN-Brain and Spine Institute

🇺🇸

Port Orange, Florida, United States

Hope Research Institute

🇺🇸

Phoenix, Arizona, United States

Arizona Research Center

🇺🇸

Phoenix, Arizona, United States

Trovare Clinical Research

🇺🇸

Bakersfield, California, United States

Velocity Clinical Research - Banning

🇺🇸

Banning, California, United States

Velocity Clinical Research - San Diego

🇺🇸

La Mesa, California, United States

Probe Clinical Research

🇺🇸

Riverside, California, United States

Pain Management and Injury Relief

🇺🇸

Thousand Oaks, California, United States

Visionary Investigators Network

🇺🇸

Aventura, Florida, United States

Nature Coast Clinical Research - Crystal River

🇺🇸

Crystal River, Florida, United States

Scroll for more (44 remaining)
ARSN-Brain and Spine Institute
🇺🇸Port Orange, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.